3-Hydroxybutyric acid sodium

filler

Catalog No. Size 价格库存数量
S0031-2 2mg solid ¥80
售罄
不可用
S0031-10 10mg solid ¥240
售罄
不可用

详情描述

3-Hydroxybutyric acid sodium (β-Hydroxybutyric acid sodium) is a metabolite that is elevated in type I diabetes. 3-Hydroxybutyric acid sodium can modulate the properties of membrane lipids.

Product information

CAS Number: 150-83-4

Molecular Weight: 126.09

Formula: C4H7NaO3

Synonym:

β-Hydroxybutyric acid sodium

Chemical Name: sodium 3-hydroxybutanoate

Smiles: [Na+].CC(O)CC([O-])=O

InChiKey: NBPUSGBJDWCHKC-UHFFFAOYSA-M

InChi: InChI=1S/C4H8O3.Na/c1-3(5)2-4(6)7;/h3,5H,2H2,1H3,(H,6,7);/q;+1/p-1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: DMSO : 32.5 mg/mL (257.75 mM; ultrasonic and warming and heat to 50°C).

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vitro:

3-Hydroxybutyric acid sodium (β-Hydroxybutyric acid sodium) is capable of interacting with lipids (modeled using a DPPC monolayer) and altering phase behavior at clinical concentrations. 3-Hydroxybutyric acid sodium also diminishes the interfacial viscosity of DPPC Monolayers.

References:

  1. Hsu TT, et al. 3-Hydroxybutyric acid interacts with lipid monolayers at concentrations that impair consciousness. Langmuir. 2013 Feb 12;29(6):1948-55.

Products are for research use only. Not for human use.

相似产品

Recently viewed